學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
Defining Capitalism's Character: Tom Peters versus McKinsey
內容大綱
In early 2021, McKinsey & Company (McKinsey) agreed to pay US$573 million to end US state-level investigations into claims that it had helped exacerbate the global opioid crisis. Tom Peters, an influential and highly respected management guru, was upset by how far his former employer had been willing to go in helping US drug maker Purdue Pharma LP increase sales of OxyContin, a narcotic-based painkiller that helped drive an opioid epidemic responsible for hundreds of thousands of tragic deaths. As far as Peters was concerned, there was no question as to whether what McKinsey did was wrong: it had ignored the "moral responsibility of business" by helping an unethical client maximize profit by aggressively promoting the wide-scale use of a highly addictive drug. In addition to asking why McKinsey was still open for business, Peters posed a previously unimaginable question: "At this moment in time, why would anyone want to go to work for McKinsey?"